HDL cholesterol: Metabolic Pathways and Drug Developments Fifth Annual International Conference of the Knowledge Foundation March 8-9, 2004, Cambridge, MA USA

Cardiovascular Drug Reviews

Volumn 22, Issue 2, 2004, Pages 147-153

  Scriabine, Alexander ^a   Wilson, Peter W F ^b   Toth, Peter P ^c   Harwood, H James ^d   Prueksatanont's, T ^e   Black, Donald M ^e   Forte, Trudy M ^f   Coppola, Gary M ^g   Feingold, Kenneth ^h   Cao, Guoquing ⁱ   Santamarina Fojo, Silvia ^j   Thompson, John F ^d   Rittershaus, Charles W ^k   Krieger's, Monty ^l   Ordovas, Jose M ^m   Kocher, Olivier ⁿ   Oram, John F ^o   Oda, Michael N ^p   Miller, Norman E ^q   Remaley, Alan T ^j   Davidson, W Sean ^r   more..

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d PFIZER INC   (United States)

^e MERCK RESEARCH LABORATORIES   (United States)

^f LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^g NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ ELI LILLY AND COMPANY   (United States)

^j NATIONAL INSTITUTES OF HEALTH   (United States)

^k AVANT Immunotherapeutics Inc   (United States)

^l MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^m TUFTS UNIVERSITY   (United States)

ⁿ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

^p CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^q Univ of Cincinnati ^*

^r UNIVERSITY OF CINCINNATI   (United States)

more..

Author keywords

Atherosclerosis; Cholesterol transport; HDL cholesterol; HDL C raising drugs; Lipoprotein metabolism; Metabolic syndrome; Nuclear receptors; Scavenger receptor B.

Indexed keywords

ACETYL COENZYME A CARBOXYLASE INHIBITOR; ANTILIPEMIC AGENT; ARYLDIALKYLPHOSPHATASE; BEZAFIBRATE; CELL NUCLEUS RECEPTOR; CERIVASTATIN; CHOLESTEROL ESTER TRANSFER PROTEIN; CIPROFIBRATE; COLESTIPOL; CP 610431; CP 640186; ENZYME INHIBITOR; EZITIMIBE; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; HDL 376; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; MEVINOLIN; NICOTINIC ACID; PDZ PROTEIN; PROTEIN PDZK1; SCAVENGER RECEPTOR; SDZ 45904; SIMVASTATIN; TO 901317; UNCLASSIFIED DRUG; VACCINE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; DRUG STRUCTURE; ENDOTHELIUM CELL; FATTY ACID SYNTHESIS; GLUCURONIDATION; HUMAN; LIPOPROTEIN METABOLISM; MEDICAL SOCIETY; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; UNITED STATES;

EID: 3042756169     PISSN: 08975957     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3466.2004.tb00137.x     Document Type: Conference Paper

References (0)